BackArriVent BioPharma Overview

ArriVent BioPharma Receivables

Latest receivables for AVBP: $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00
↓ 100.00% YoYΔ $-505000.00 vs prior year quarter

Peer trimmed avg / median

Loading

ArriVent BioPharma Receivables History

Loading

ArriVent BioPharma vs. peers: Receivables Comparison

Loading

ArriVent BioPharma Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

ArriVent BioPharma (AVBP) FAQ

ArriVent BioPharma (AVBP) currently reports a receivables of $0 as of June 2026. That compares with $510K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore ArriVent BioPharma's receivables history and peer comparisons.

ArriVent BioPharma's receivables decreased from $510K to $0 — a 100.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ArriVent BioPharma reported $0 in receivables as of June 2026. That compares with $510K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ArriVent BioPharma, and consider following AVBP for alerts when major investors trade the stock.